Iovance Biotherapeutics (IOVA) Institutional Ownership

$8.17 +0.16 (+2.00%)

As of 04:00 PM Eastern

Current Institutional Ownership Percentage: 77.03%
Number of Institutional Buyers (last 12 months): 146
Total Institutional Inflows (last 12 months): $350.25M

Number of Institutional Sellers (last 12 months): 54
Total Institutional Outflows (last 12 months): $66.37M

Get IOVA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Iovance Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IOVA Institutional Buying and Selling by Quarter

Iovance Biotherapeutics Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/27/2026	Corient Private Wealth LP	55,275	$230K	0.0%	N/A	0.012%
8/26/2026	HighTower Advisors LLC	14,435	$60K	0.0%	N/A	0.003%
8/25/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	108,050	$449K	0.0%	N/A	0.024%
8/24/2026	California State Teachers Retirement System	1,651,316	$6.87M	0.0%	+459.0%	0.365%
8/23/2026	HB Wealth Management LLC	13,461	$56K	0.0%	N/A	0.003%
8/22/2026	Syon Capital LLC	13,003	$54K	0.0%	N/A	0.003%
8/21/2026	AXQ Capital LP	62,915	$262K	0.0%	+28.7%	0.014%
8/20/2026	Headlands Technologies LLC	138,839	$578K	0.1%	-9.3%	0.031%
8/20/2026	GTS Securities LLC	14,461	$60K	0.0%	+44.6%	0.003%
8/20/2026	Wedbush Securities Inc.	145,473	$605K	0.0%	N/A	0.032%
Get the Latest News and Ratings for IOVA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Iovance Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter.
8/19/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	526,646	$2.19M	0.0%	+11.1%	0.116%
8/19/2026	Hsbc Holdings PLC	68,190	$292K	0.0%	+148.1%	0.015%
8/19/2026	Wellington Management Group LLP	127,740	$531K	0.0%	N/A	0.028%
8/18/2026	Palo Alto Investors LP	5,296,209	$22.03M	0.0%	N/A	1.169%
8/17/2026	Corient Private Wealth LP	52,864	$220K	0.0%	N/A	0.012%
8/17/2026	Bank of America Corp DE	4,993,584	$20.77M	0.0%	N/A	1.102%
8/15/2026	Freestone Grove Partners LP	42,858	$178K	0.0%	N/A	0.009%
8/15/2026	Man Group plc	252,959	$1.05M	0.0%	N/A	0.056%
8/15/2026	Jupiter Topco LLC	141,672	$589K	0.0%	N/A	0.031%
8/14/2026	ADAR1 Capital Management LLC	146,090	$608K	0.0%	N/A	0.032%
8/14/2026	Hsbc Holdings PLC	68,190	$292K	0.0%	N/A	0.015%
8/14/2026	EFG International AG	40,000	$166K	0.0%	N/A	0.009%
8/14/2026	Legal & General Group Plc	259,485	$1.08M	0.0%	N/A	0.057%
8/14/2026	The Manufacturers Life Insurance Company	262,147	$1.09M	0.0%	N/A	0.058%
8/14/2026	Algert Global LLC	474,939	$1.98M	0.0%	+62.1%	0.105%
8/13/2026	Portland Investment Counsel Inc.	130,000	$541K	0.2%	N/A	0.029%
8/13/2026	Sanctuary Advisors LLC	13,284	$55K	0.0%	N/A	0.003%
8/12/2026	Commerce Bank	19,000	$79K	0.0%	N/A	0.004%
8/12/2026	Ieq Capital LLC	292,962	$1.22M	0.0%	N/A	0.065%
8/11/2026	Allworth Financial LP	13,668	$57K	0.0%	N/A	0.003%
8/11/2026	E Fund Management Co. Ltd.	56,806	$236K	0.0%	N/A	0.013%
8/8/2026	Wealthfront Advisers LLC	12,959	$54K	0.0%	N/A	0.003%
8/7/2026	Grandfield & Dodd LLC	62,520	$260K	0.0%	N/A	0.014%
8/7/2026	BlackRock Inc.	36,957,681	$153.74M	0.0%	N/A	8.277%
8/7/2026	Deutsche Bank AG	854,973	$3.56M	0.0%	N/A	0.191%
8/7/2026	Rice Hall James & Associates LLC	1,539,840	$6.41M	0.3%	N/A	0.345%
8/7/2026	Mitsubishi UFJ Asset Management Co. Ltd.	64,724	$269K	0.0%	N/A	0.014%
8/7/2026	First National Bank & Trust Co. of Newtown	12,500	$51K	0.0%	N/A	0.003%
8/6/2026	Flputnam Investment Management Co.	25,950	$108K	0.0%	N/A	0.006%
8/6/2026	Bank of New York Mellon Corp	1,162,097	$4.83M	0.0%	N/A	0.260%
Buy this stock today (Ad) Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race. Get the name, ticker, and full Hotlist before markets open
8/6/2026	GSA Capital Partners LLP	655,318	$2.73M	0.2%	N/A	0.147%
7/10/2026	Tema ETFs LLC	280,048	$1.17M	0.0%	+52.1%	0.063%
7/9/2026	Centurion Wealth Management LLC	69,168	$288K	0.1%	+18.5%	0.015%
7/9/2026	Hennion & Walsh Asset Management Inc.	818,913	$3.41M	0.1%	+100.0%	0.183%
7/7/2026	Mirador Capital Partners LP	1,080,288	$4.49M	0.6%	+0.7%	0.242%
6/2/2026	Optiver Holding B.V.	36,660	$129K	0.0%	+24.0%	0.008%
5/19/2026	Bank of America Corp DE	8,490,119	$29.80M	0.0%	-40.5%	1.901%
5/19/2026	Janus Henderson Group PLC	141,672	$498K	0.0%	+55.1%	0.032%
5/19/2026	Arkadios Wealth Advisors	20,262	$71K	0.0%	N/A	0.005%
5/18/2026	Royal Bank of Canada	625,035	$2.19M	0.0%	+2.7%	0.140%
5/16/2026	The Manufacturers Life Insurance Company	365,471	$1.28M	0.0%	+57.9%	0.082%
5/15/2026	Corsair Capital Management L.P.	350,000	$1.23M	0.2%	+16.7%	0.078%
5/15/2026	Rice Hall James & Associates LLC	1,514,907	$5.32M	0.3%	+6.3%	0.339%
5/14/2026	Knott David M Jr	1,600,000	$5.62M	3.3%	N/A	0.358%
5/14/2026	Sei Investments Co.	122,180	$429K	0.0%	+15.7%	0.027%
5/13/2026	Cetera Investment Advisers	31,094	$109K	0.0%	-56.0%	0.007%
5/8/2026	PNC Financial Services Group Inc.	25,052	$88K	0.0%	-50.7%	0.006%
5/7/2026	Dimensional Fund Advisors LP	2,645,702	$9.28M	0.0%	+71.9%	0.593%
5/7/2026	KBC Group NV	9,586	$34K	0.0%	N/A	0.002%
5/6/2026	Annis Gardner Whiting Capital Advisors LLC	100,400	$352K	0.1%	N/A	0.022%
5/6/2026	Ceera Investments LLC	12,465	$44K	0.0%	N/A	0.003%
5/5/2026	Sanctuary Advisors LLC	10,968	$38K	0.0%	N/A	0.002%
5/4/2026	Chicago Partners Investment Group LLC	52,653	$186K	0.0%	+29.7%	0.012%
5/1/2026	Fifth Third Bancorp	11,230	$39K	0.0%	N/A	0.003%
5/1/2026	Sequoia Financial Advisors LLC	31,266	$110K	0.0%	N/A	0.007%
4/30/2026	Hsbc Holdings PLC	27,484	$98K	0.0%	-84.8%	0.006%
4/30/2026	Kestra Advisory Services LLC	34,891	$122K	0.0%	+242.4%	0.008%
4/30/2026	Granite Investment Partners LLC	18,843	$66K	0.0%	+77.1%	0.005%
4/29/2026	R Squared Ltd	26,883	$94K	0.1%	-22.2%	0.007%
4/28/2026	Abel Hall LLC	24,406	$86K	0.0%	N/A	0.006%
4/27/2026	Leonteq Securities AG	160,000	$562K	0.0%	-17.9%	0.039%
4/22/2026	Pictet Asset Management Holding SA	43,048	$151K	0.0%	+58.7%	0.010%
4/22/2026	Sterling Capital Management LLC	11,177	$39K	0.0%	-36.9%	0.003%
4/21/2026	Sugar Maple Asset Management LLC	120,000	$421K	0.3%	+9.1%	0.029%
4/21/2026	Penbrook Management LLC	42,445	$149K	0.1%	+25.0%	0.010%
4/17/2026	Krilogy Financial LLC	15,376	$58K	0.0%	N/A	0.004%
4/16/2026	SG Americas Securities LLC	167,878	$589K	0.0%	+203.1%	0.041%
3/20/2026	Hsbc Holdings PLC	180,541	$497K	0.0%	+651.5%	0.044%
3/17/2026	Rockefeller Capital Management L.P.	50,726	$138K	0.0%	+187.6%	0.012%
3/3/2026	Caitong International Asset Management Co. Ltd	47,277	$129K	0.0%	+658.9%	0.011%
2/19/2026	Invesco Ltd.	1,251,665	$3.42M	0.0%	+32.4%	0.315%
2/18/2026	XTX Topco Ltd	522,934	$1.43M	0.0%	+148.4%	0.132%
2/18/2026	VARCOV Co.	92,806	$253K	0.1%	N/A	0.023%
2/18/2026	Virtus Investment Advisers LLC	310,641	$848K	0.2%	+61.5%	0.078%
2/18/2026	Tudor Investment Corp ET AL	179,494	$490K	0.0%	+47.4%	0.045%
2/18/2026	Quadrature Capital Ltd	318,703	$870K	0.0%	N/A	0.080%
2/18/2026	One68 Global Capital LLC	20,000	$55K	0.6%	N/A	0.005%
2/18/2026	Perceptive Advisors LLC	152,714	$417K	0.0%	N/A	0.038%
2/18/2026	Intrepid Family Office LLC	30,000	$82K	0.1%	-25.0%	0.008%
2/18/2026	Invenomic Capital Management LP	11,959,505	$32.65M	1.5%	+13.5%	3.013%
The end may be near for these iconic stocks (Ad) Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required. Watch Marc Chaikin's free presentation and get his full buy-and-sell list today
2/18/2026	Engineers Gate Manager LP	194,691	$532K	0.0%	N/A	0.049%
2/18/2026	First Manhattan CO. LLC.	28,998	$79K	0.0%	-46.6%	0.007%
2/18/2026	Balyasny Asset Management L.P.	68,038	$186K	0.0%	-24.9%	0.017%
2/17/2026	AQR Capital Management LLC	110,591	$302K	0.0%	+9.1%	0.028%
2/17/2026	Cetera Investment Advisers	70,674	$193K	0.0%	-7.0%	0.018%
2/17/2026	EFG International AG	168,000	$459K	0.0%	N/A	0.042%
2/17/2026	Jain Global LLC	312,096	$852K	0.0%	N/A	0.079%
2/17/2026	Jump Financial LLC	22,062	$60K	0.0%	N/A	0.006%
2/17/2026	Price T Rowe Associates Inc. MD	1,191,828	$3.26M	0.0%	-42.1%	0.300%
2/17/2026	Osaic Holdings Inc.	102,155	$279K	0.0%	-4.0%	0.026%

IOVA Institutional Ownership - Frequently Asked Questions

During the previous two years, 296 institutional investors and hedge funds held shares of Iovance Biotherapeutics. The most heavily invested institutionals were BlackRock Inc. ($153.74M), Vanguard Group Inc. ($74.28M), Hood River Capital Management LLC ($66.54M), State Street Corp ($55.04M), Artisan Partners Limited Partnership ($33.61M), Invenomic Capital Management LP ($32.65M), and Avoro Capital Advisors LLC ($25.90M).Learn more on Iovance Biotherapeutics' institutional investors.

77.03% of Iovance Biotherapeutics' stock is owned by institutional investors. Learn more on IOVA's institutional investor holdings.

Of the 259 institutional investors that purchased Iovance Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($36.96M), Palo Alto Investors LP ($9.65M), Invenomic Capital Management LP ($9.15M), Bank of America Corp DE ($8.26M), State Street Corp ($7.43M), Long Focus Capital Management LLC ($4.72M), and Principal Financial Group Inc. ($4.04M).

Institutional investors have bought a total of 100,289,368 shares in the last 24 months. This purchase volume represents approximately $350.25M in transactions.

Of the 54 institutional investors that sold Iovance Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Bank of America Corp DE ($5.79M), Millennium Management LLC ($4.92M), Long Focus Capital Management LLC ($2.70M), Two Sigma Investments LP ($1.89M), Principal Financial Group Inc. ($1.59M), Dimensional Fund Advisors LP ($1.39M), and Vanguard Group Inc. ($1.02M).

Institutional investors have sold a total of 25,779,069 shares in the last 24 months. This volume of shares sold represents approximately $66.37M in transactions.

Related Companies

Institutional ownership data for NASDAQ:IOVA is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/27/2026. New 13F filings are added each quarter as they're published.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Iovance Biotherapeutics (IOVA) Institutional Ownership

IOVA Institutional Buying and Selling by Quarter

Iovance Biotherapeutics Major Shareholders & Ownership History

IOVA Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Iovance Biotherapeutics (IOVA) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Iovance Biotherapeutics (NASDAQ:IOVA)

IOVA Institutional Buying and Selling by Quarter

Iovance Biotherapeutics Major Shareholders & Ownership History

IOVA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of IOVA shares?

What percentage of Iovance Biotherapeutics' stock is owned by institutional investors?

Which institutional investors have been buying Iovance Biotherapeutics' stock?

How much institutional buying is happening at Iovance Biotherapeutics?

Which of Iovance Biotherapeutics' major shareholders have been selling company stock?

How much institutional selling is happening at Iovance Biotherapeutics?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools